Paclitaxel-loaded and folic acid-modified PLGA nanomedicine with glutathione response for the treatment of lung cancer.

Acta Biochimica Et Biophysica Sinica
Wang YaoJianhui Tian

Abstract

Targeted delivery and smart response of nanomedicine hold great promise for improving the therapeutic efficacy and alleviating the side effects of chemotherapy agents in cancer treatment. However, availability of only a few studies that discuss organic nanomedicines with these properties limits the development prospects of nanomedicines. In the present study, folic acid (FA)-targeted delivery and glutathione (GSH) smart responsive nanomedicine were rationally designed for paclitaxel (PTX) delivery for the treatment of lung cancer. Compared with other stimuli-responsive nanomedicines, this nanocarrier was not only sensitive to biologically relevant GSH for on-demand drug release but also biodegradable into biocompatible products after fulfilling its delivery task. The nanomedicine first entered tumor cells via FA and its receptor-mediated endocytosis. After the lysosomal escape, poly(lactic-co-glycolic acid) (PLGA) nanomedicine was triggered by a higher level of GSH and released its cargo into the tumor microenvironment. In vitro and in vivo results revealed that the PLGA nanomedicine not only inhibited the proliferation and promoted the apoptosis of lung cancer cells significantly but also possessed less toxic side effects when...Continue Reading

References

Jan 1, 1993·Gynecologic and Obstetric Investigation·T C ChangS Hsueh
Mar 11, 2010·Methods in Molecular Biology·Alexander Gaitanis, Stephen Staal
Jan 10, 2013·Journal of the American Chemical Society·Zhanxia ZhangItamar Willner
Aug 6, 2015·Drug Design, Development and Therapy·Madappa N Kundranda, Jiaxin Niu
Aug 11, 2015·ACS Nano·Sulin ZhangGang Bao
Nov 7, 2015·Drugs·Hannah A Blair, Emma D Deeks
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jul 7, 2016·Immunotherapy·Thomas CarterKerry Chester
Sep 22, 2016·Critical Reviews in Therapeutic Drug Carrier Systems·Iliyas KhanUmesh Gupta
Nov 23, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·F Danhier
Feb 16, 2017·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Y Lee, D H Thompson
Jun 20, 2018·The Journal of Cell Biology·Ankita Bansal, M Celeste Simon
Oct 31, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Somayeh HandaliFarid Abedin Dorkoosh
May 17, 2019·Acta Biomaterialia·Sakineh HajebiMichael R Hamblin
Jun 12, 2019·CA: a Cancer Journal for Clinicians·Kimberly D MillerRebecca L Siegel
Jul 10, 2019·Oxidative Medicine and Cellular Longevity·Huanhuan LvPeng Shang
Jul 14, 2019·Colloids and Surfaces. B, Biointerfaces·Zhanxia ZhangHongbin Ji
Dec 1, 2019·Biomolecules·Tala M Abu SamaanDietrich Büsselberg
Jan 7, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Zhanxia ZhangLijun Jia
Jan 16, 2020·Theranostics·Mengnan ZhaoRaymond M Schiffelers
Apr 1, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Alejandro Baeza

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis